Bukowska-Ośko I - Search Results

1

CD8⁺ T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation.

Osuch S, Laskus T, Perlejewski K, Berak H, Bukowska-Ośko I, Pollak A, Zielenkiewicz M, Radkowski M, Caraballo Cortés K. Osuch S, et al. Among authors: bukowska osko i. Front Immunol. 2022 Mar 21;13:832206. doi: 10.3389/fimmu.2022.832206. eCollection 2022. Front Immunol. 2022. PMID: 35386708 Free PMC article.

2

Virus-Specific Cellular Response in Hepatitis C Virus Infection.

Kaźmierczak J, Caraballo Cortes K, Bukowska-Ośko I, Radkowski M. Kaźmierczak J, et al. Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):101-10. doi: 10.1007/s00005-015-0364-8. Epub 2015 Oct 1. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26429740 Free article. Review.

3

Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.

Caraballo Cortés K, Osuch S, Perlejewski K, Pawełczyk A, Kaźmierczak J, Janiak M, Jabłońska J, Nazzal K, Stelmaszczyk-Emmel A, Berak H, Bukowska-Ośko I, Paciorek M, Laskus T, Radkowski M. Caraballo Cortés K, et al. J Viral Hepat. 2019 Aug;26(8):942-950. doi: 10.1111/jvh.13108. Epub 2019 Apr 29. J Viral Hepat. 2019. PMID: 30972915 Free PMC article.

4

Hepatitis C virus (HCV) genotype 1b displays higher genetic variability of hypervariable region 1 (HVR1) than genotype 3.

Janiak M, Perlejewski K, Grabarczyk P, Kubicka-Russel D, Zagordi O, Berak H, Osuch S, Pawełczyk A, Bukowska-Ośko I, Płoski R, Laskus T, Caraballo Cortés K. Janiak M, et al. Among authors: bukowska osko i. Sci Rep. 2019 Sep 6;9(1):12846. doi: 10.1038/s41598-019-49258-y. Sci Rep. 2019. PMID: 31492939 Free PMC article.

5

Ultradeep pyrosequencing of hepatitis C virus hypervariable region 1 in quasispecies analysis.

Caraballo Cortés K, Zagordi O, Laskus T, Płoski R, Bukowska-Ośko I, Pawełczyk A, Berak H, Radkowski M. Caraballo Cortés K, et al. Biomed Res Int. 2013;2013:626083. doi: 10.1155/2013/626083. Epub 2013 Apr 28. Biomed Res Int. 2013. PMID: 23710455 Free PMC article.

6

Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.

Radkowski M, Opoka-Kegler J, Cortes KC, Bukowska-Ośko I, Perlejewski K, Pawełczyk A, Laskus T. Radkowski M, et al. J Gen Virol. 2014 Sep;95(Pt 9):2004-2009. doi: 10.1099/vir.0.064709-0. Epub 2014 Jun 11. J Gen Virol. 2014. PMID: 24920726

7

Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome.

Cortés KC, Zagordi O, Perlejewski K, Laskus T, Maroszek K, Bukowska-Ośko I, Pawełczyk A, Płoski R, Berak H, Horban A, Radkowski M. Cortés KC, et al. BMC Infect Dis. 2014 Jul 13;14:389. doi: 10.1186/1471-2334-14-389. BMC Infect Dis. 2014. PMID: 25016390 Free PMC article.

8

Analysis of genotype 1b hepatitis C virus IRES in serum and peripheral blood mononuclear cells in patients treated with interferon and ribavirin.

Bukowska-Ośko I, Caraballo Cortés K, Pawełczyk A, Płoski R, Fic M, Perlejewski K, Demkow U, Berak H, Horban A, Laskus T, Radkowski M. Bukowska-Ośko I, et al. Biomed Res Int. 2014;2014:175405. doi: 10.1155/2014/175405. Epub 2014 Jul 3. Biomed Res Int. 2014. PMID: 25136559 Free PMC article. Clinical Trial.

9

Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.

Bukowska-Ośko I, Pawełczyk A, Perlejewski K, Kubisa N, Caraballo Cortés K, Rosińska M, Płoski R, Fic M, Kaźmierczak J, Popiel M, Ząbek P, Horban A, Radkowski M, Laskus T. Bukowska-Ośko I, et al. PLoS One. 2015 May 1;10(5):e0125604. doi: 10.1371/journal.pone.0125604. eCollection 2015. PLoS One. 2015. PMID: 25932941 Free PMC article.

10

The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.

Jabłońska J, Pawłowski T, Laskus T, Zalewska M, Inglot M, Osowska S, Perlejewski K, Bukowska-Ośko I, Cortes KC, Pawełczyk A, Ząbek P, Radkowski M. Jabłońska J, et al. BMC Infect Dis. 2015 Dec 4;15:556. doi: 10.1186/s12879-015-1305-1. BMC Infect Dis. 2015. PMID: 26637466 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page